You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GVHD.

Showing 1 - 25 of 2,346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Intestinal GVHD Trial in Rome (shear wave elastography)

Recruiting
  • Intestinal GVHD
  • shear wave elastography
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli
Mar 27, 2023

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)

Recruiting
  • GVHD,Acute
  • GVHD, Chronic
  • Physical exercise
  • Salamanca, Spain
    University of Salamanca
May 27, 2022

GVHD Trial in Chicago (Expressive Writing)

Not yet recruiting
  • Graft Versus Host Disease
  • Expressive Writing
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
Jan 12, 2023

Photopheresis in GvHD After Hematopoietic Transplantation:

Enrolling by invitation
  • Graft Vs Host Disease
  • Extracorporeal Photopheresis
  • Extracorporeal Photopheresis
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023

Hematopoietic Stem Cell Transplantation Trial in Ann Arbor (Bob's Red Mill®, Starch Placebo)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Bob's Red Mill®
  • Starch Placebo
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Dec 20, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

Active, not recruiting
  • GVHD, Chronic
  • Hematological Malignancy
  • Lee Symptom Scala
  • Copenhagen, Denmark
    Rigshospitalet
Jul 14, 2022

Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)

Active, not recruiting
  • Graft Vs Host Disease
  • GVHD
  • Tampa, Florida
  • +1 more
Jul 27, 2022

GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))

Not yet recruiting
  • Graft Versus Host Disease
  • Allogeneic mesenchymal stromal cells (MSCs)
  • Extracorporeal photopheresis (ECP)
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022

Chronic GVHD Trial in Shanghai (SHR0302, Prednisone)

Recruiting
  • Chronic GVHD
  • Shanghai, Shanghai, China
  • +1 more
Aug 4, 2022

Cytomegalovirus Infections Trial (Cytotect®CP)

Recruiting
  • Cytomegalovirus Infections
  • Lille, France
    Hop Claude Huriez Chu Lille
Nov 8, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Ocular Surface Disease in Chronic Graft-Versus-Host Disease

Recruiting
  • Dry Eye
  • GVHD
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

Relationship Between "FODMAPs" and "GVHD"

Recruiting
  • Graft Versus Host Disease
    • Suzhou, Jiangsu, China
      中国
    Mar 26, 2022

    The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

    Not yet recruiting
    • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
    • Ruxolitinib 5 MG BID Oral Tablet
    • (no location specified)
    Jun 13, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Lymphoma, Leukemia Trial (Acalabrutinib, tacrolimus, methotrexate)

    Withdrawn
    • Lymphoma
    • Leukemia
    • Acalabrutinib, tacrolimus, methotrexate
    • (no location specified)
    Feb 20, 2022